AB
Therapeutic Areas
AVaTAR MedTech Pipeline
| Drug | Indication | Phase |
|---|---|---|
| AVaTAR | Aortic and pulmonary valve disease (pediatric and adult) | Preclinical/Early Clinical |
Leadership Team at AVaTAR MedTech
TA
Tomás Armendariz
CEO & Co‑Founder
DI
Dr. Ignacio Lugones
CSO & Co‑Founder
MC
Martin Chilo
Research & Development Project Lead
MM
Miranda Mochen
Business Analyst
DR
David Rivero
Head of Device Development
MN
Martina Nudelman
Research & Development Analyst
IM
Inés Martinez
Cardiologist